MINARIS Trademark

Trademark Overview


On Wednesday, July 1, 2020, a trademark application was filed for MINARIS with the United States Patent and Trademark Office. The USPTO has given the MINARIS trademark a serial number of 90030815. The federal status of this trademark filing is REGISTERED as of Tuesday, July 26, 2022. This trademark is owned by HITACHI CHEMICAL COMPANY, LTD.. The MINARIS trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Contract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; information, advice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapies, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration

Medical services, namely, contracted cell culturing and tissue culturing for medical purposes; medical advisory services, namely, advisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical services, namely, separation and cultivation of body tissues and cells for medical purposes; information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medical, medicinal and pharmaceutical consultancy; isolation, collection and preservation of blood components including cells or stem cells obtained from umbilical cord blood, bone marrow, placenta and other parts of the human body, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, and cells of human or animal origin

quality control services in the field of cell culture and tissue culture, and consultancy relating thereto; quality control of cell and living tissue for others; Pharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of...
minaris

General Information


Serial Number90030815
Word MarkMINARIS
Filing DateWednesday, July 1, 2020
Status700 - REGISTERED
Status DateTuesday, July 26, 2022
Registration Number6799894
Registration DateTuesday, July 26, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements


Goods and ServicesContract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; information, advice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapies, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration
Goods and ServicesMedical services, namely, contracted cell culturing and tissue culturing for medical purposes; medical advisory services, namely, advisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical services, namely, separation and cultivation of body tissues and cells for medical purposes; information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medical, medicinal and pharmaceutical consultancy; isolation, collection and preservation of blood components including cells or stem cells obtained from umbilical cord blood, bone marrow, placenta and other parts of the human body, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, and cells of human or animal origin
Goods and Servicesquality control services in the field of cell culture and tissue culture, and consultancy relating thereto; quality control of cell and living tissue for others; Pharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnology, and advisory services relating thereto; contracted development of biological cell manufacturing process; scientific laboratory services, namely, the cultivation or modification of hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration into living drugs

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRESONAC CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type29 - NOT AVAILABLE
AddressTOKYO 105-8518
JP

Party NameSHOWA DENKO MATERIALS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type29 - NOT AVAILABLE
AddressCHIYODA-KU, TOKYO 100-6606
JP

Party NameSHOWA DENKO MATERIALS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type29 - NOT AVAILABLE
AddressCHIYODA-KU, TOKYO 100-6606
JP

Party NameSHOWA DENKO MATERIALS CO., LTD.
Party Type11 - New Owner Before Publication
Legal Entity Type29 - NOT AVAILABLE
AddressCHIYODA-KU, TOKYO 100-6606
JP

Party NameHITACHI CHEMICAL COMPANY, LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChiyoda-ku, Tokyo 100-6606
JP

Trademark Events


Event DateEvent Description
Saturday, July 4, 2020NEW APPLICATION ENTERED
Wednesday, July 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 6, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Tuesday, October 6, 2020SUSPENSION LETTER WRITTEN
Tuesday, October 6, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 31, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 6, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 28, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, August 31, 2021INQUIRY TO SUSPENSION E-MAILED
Tuesday, August 31, 2021SUSPENSION INQUIRY WRITTEN
Monday, February 28, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, March 1, 2022ASSIGNED TO LIE
Wednesday, March 2, 2022ASSIGNED TO LIE
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, March 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 4, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 3, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 26, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, July 11, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY